Article: Unveiling the Eris Subvariant: The Next Challenge in the COVID-19 Pandemic?
Journal of Laboratory Physicians
2023
Abstract: Since the COVID-19 pandemic's onset, the SARS-CoV-2 virus has displayed remarkable mutation abilities, resulting in distinct variants. Alpha, Beta, Gamma, Delta, and Omicron are major World Health Organization (WHO)-identified variants of concern. The ... ...
Abstract | Since the COVID-19 pandemic's onset, the SARS-CoV-2 virus has displayed remarkable mutation abilities, resulting in distinct variants. Alpha, Beta, Gamma, Delta, and Omicron are major World Health Organization (WHO)-identified variants of concern. The Omicron variant and its sub-lineages dominated globally in 2022. A novel strain, EG.5.1 (Eris), originating from Omicron's XBB sub-lineage, has recently sparked a significant COVID-19 surge across continents. Detected since June 2023, EG.5.1 is linked to increased cases in Europe, the Americas, and Asia. Factors like waning immunity, overcrowding, and poor air quality contributed to its rise. This variant is likely to prevail over other circulating variants and become dominant in UK by September 2023. Surveillance of its global epidemiology and implementing preventive measures have become imperative in light of the current situation. |
---|---|
Keywords | EG.5.1 ; Eris subvariant ; SARS-CoV-2 |
Language | English |
Publishing date | 2023-09-08 |
Publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
Publishing place | Stuttgart ; New York |
Document type | Article |
ZDB-ID | 2461120-7 |
ISSN | 0974-7826 ; 0974-2727 ; 0974-7826 |
ISSN (online) | 0974-7826 |
ISSN | 0974-2727 ; 0974-7826 |
DOI | 10.1055/s-0043-1774410 |
Database | Thieme publisher's database |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.